α-amylase inhibitors: A review of raw material and isolated compounds from plant source

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 15, Issue 1, 2012, Pages 141-183

  de Sales, Paloma Michelle ^a   de Souza, Paula Monteiro ^a   Simeoni, Luiz Alberto ^a   Magalhães, Pérola de Oliveira ^a   Silveira, Dâmaris ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; AMYLASE; AMYLASE INHIBITOR; AZADIRACHTA INDICA EXTRACT; BOUGAINVILLEA SPECTABILIS EXTRACT; CORTICOSTEROID DERIVATIVE; EMBELIA RIBES EXTRACT; FLAVONOID; GALACTOMANNAN; GLYCOPEPTIDE; GLYCOSIDE; GUANIDINE; GUAVA EXTRACT; HYDROXYL GROUP; HYPOGLYCAN DERIVATIVE; MANGIFERA INDICA EXTRACT; MARRUBIUM RADIATUM EXTRACT; MURRAYA KOENIGII EXTRACT; OCIMUM TENUIFLORUM EXTRACT; PEPTIDOGLYCAN; PHENOL DERIVATIVE; PHYLLANTHUS MADERASPATENSIS EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; PUNICA GRANATUM EXTRACT; SALVIA ACETABULOSA EXTRACT; SYZYGIUM CUMINI EXTRACT; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; AYURVEDA; AZADIRACHTA INDICA; BOUGAINVILLEA SPECTABILIS; CHEMICAL COMPOSITION; DIABETES MELLITUS; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; EMBELIA RIBES; ENZYME BINDING; ENZYME INHIBITION; HUMAN; MARRUBIUM; MARRUBIUM RADIATUM; MEDICINAL PLANT; NONHUMAN; OCIMUM TENUIFLORUM; PHYLLANTHUS; PHYLLANTHUS MADERASPATENSIS; PHYTOCHEMISTRY; REVIEW; SALVIA; SALVIA ACETABULOSA; STRUCTURE ANALYSIS;

EID: 84857082127     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j35s3k     Document Type: Review

References (81)

1. Laar FA, Lucassen PLBJ, Akkermans RP, Lisdonk EH, Rutten GEHM, Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus (Cochrane Review). The Cochrane Library, 2008.
2. Yanovski SZ, Yanovski JA. Drug Therapy: Obesity. N. Engl. J. Med., 2002; 346: 5991-602.
3. Touger-Decker R, Loveren CV. Sugars and dental caries. Am. J. Clin. Nutr., 2003; 78: 88S-92S.
4. Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes Mellitus. Can. Med. Assoc. J., 2005; 172: 213-226.
5. Aguiar LGK, Villela NR, Bouskela EA. Microcirculação no Diabetes: Implicações nas Complicações Crônicas e Tratamento da Doença. Arq Bras Endocrinol Metab 2007; 51: 204-211.
6. Funke I, Melzing MF. Traditionally used plants in diabetes therapy-phytotherapeutics as inhibitors of a-amylase activity. Rev Bras Farmacogn, 2006; 16: 1-5.
7. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA, 2002; 287: 360-372.
8. Chakrabarti R, Rajagopalan R. Diabetes and insulin resistance associated disorders: Disease and the therapy. Current Sci, 2002; 83: 1533-1538.
9. Goke B, Herrmann-Rinke C. The evolving role of alpha-glucosidase inhibitors. Diabetes/Metab Res, 1998; 14: S31-S38.
10. Lebowitz HE. alpha-glucosidase inhibitors as agents in the treatment of diabetes Diabetes Rev, 1998; 6: 132-145.
11. Rudney JD. Saliva and dental plaque. Adv. Dental Res., 2000; 14: 29-39.
12. Ramasubbu N, Paloth V, Luo Y, Brayer GD, Levine MJ. Structure of human salivary alphaamylase at 1.6 A resolution: implications for its role in the oral cavity. Acta Crystallogr., Sect. D.: Biol. Crystallogr, 1996; 52: 435-446.
13. Scannapieco FA, Torres G, Levine MJ. Salivary α-amylase: role in dental plaque and caries formation. Crit. Rev. Oral Biol. Med., 1993; 4: 301-307.
14. Bernfeld P. Amylases α and β. In Methods in Enzymology, Colowick, S. P.; Kaplan, N. O., Eds. Academic Press, Inc: San Diego, 1955; Vol. 1, pp 149-158.
15. Mosca M, Boniglia C, Carrat B, Giammarioli S, Nera V, Sanzini E. Determination of [alpha]-amylase inhibitor activity of phaseolamin from kidney bean (Phaseolus vulgaris) in dietary supplements by HPAEC-PAD. Anal Chim Acta, 2008; 617: 192-195.
16. Whitcomb DC, Lowe ME. Human Pancreatic Digestive Enzymes. Digestive Diseases Sciences, 2007; 52: 1-17.
17. Kandra L. α-Amylases of medical and industrial importance. J. Mol. Struct., 2003; 666-667: 487-498.
18. Brayer GD, Luo Y, Withers SG. The structure of human pancreatic a-amylase at 1.8 A resolution and comparisons with related enzymes. Protein Sci, 1995; 4: 1730-1742.
19. Tangphatsornruang S, Naconsie M, Thammarongtham C, Narangajavana J. Isolation and characterization of an a-amylase gene in cassava (Manihot esculenta). Plant Physiol. Biochem., 2005; 43: 821-827.
20. Iulek J, Franco OL, Silva M, Slivinski CT, Bloch Jr C, Rigden DJ, Sám FG. Purification, biochemical characterisation and partial primary structure of a new α-amylase inhibitor from Secale cereale (rye). Int. J. Biochem. Cell Biol, 2000; 32: 1195-1204.
21. Maarel MJEC, Veen B, Uitdehaag JCM, Leemhuis H, Dijkhuizen L. Properties and applications of starch-converting enzymes of the α-amylase family. J. Biotechnol., 2002; 94: 137-155
22. Groot PC, Bleeker MJ, Pronk JC, Arwert F, Mager WH, Planta RJ, Eriksson AW, Frants RR. Human pancreatic amylase is encoded by two different genes. Nucleic Acids Res, 1988; 16: 4724.
23. Gumucio DL, Wiebauer K, Caldwell RM, Samuelson LC, Meisler MH. Concerted evolution of human amylase genes. Mol Cell Biol, 1988; 8: 1197-1205.
24. Van der Maarel MJEC, Van der Veen B, Uitdehaag JC, Leemhuis H, Dijkhuizen L. Properties and applications of starch-converting enzymes of the α-amylase family J. Biotechnol., 2002; 94: 137-155.
25. Janecek S, Svensson B, Henrissat B. Domain evolution in the α-amylase family. J. Mol. Evol., 1997; 45: 322-331.
26. Brayer GD, Sidhu G, Maurus R, Rydberg EH, Braun C, Wang Y, Nguyen NT, Overall CM, Withers SG. Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic and mutagenesis techniques. Biochemistry-US, 2000; 39: 4778-4791.
27. Rydberg EH, Li C, Maurus R, Overall CM, Brayer GD, Withers SG. Mechanistic analyses of catalysis in human pancreatic α-amylase: Detailed kinetic and structural studies of mutants of three conserved carboxylic acids. Biochemistry, 2002; 41: 4492-4502.
28. Mentreddy SR. Medicinal plant species with potential antidiabetic properties. J. Sci. Food Agric., 2007; 87: 743-750.
29. Karthic K, Kirthiram KS, Sadasivam S, Thayumanavan B. Identification of α-amylase inhibitors from Syzygium cumini Linn seeds. Indian J. Exp. Biol., 2008; 46: 677-680.
30. Kumar A, Ilavarasan R, Jayachandran T, Deecaraman M, Aravindan P, Padmanabhan N, Krishan M. Anti-diabetic activity of Syzygium cumini and it's isolated compound against streptozotocin-induced diabetic rats. J. Med. Plants Res., 2008; 2: 246-249.
31. Conforti F, Statti G, Loizzo MR, Sacchetti G, Poli F, Menichini F. In Vitro Antioxidant Effect and Inhibition of a-Amylase of Two Varieties of Amaranthus caudatus Seeds. Biol Pharm Bull, 2005; 28: 1098-1102.
32. Kobayashi K, Baba E, Fushiya S, Takano F, Batkhuu J, Dash T, Sanchir C, Yoshizaki F. Screening of Mongolian Plants for Influence on Amylase Activity in Mouse Plasma and Gastrointestinal Tube. Biol. Pharm. Bull., 2003; 26: 1045-1048.
33. Loizzo MR, Saab AM, Tundis R, Menichini F, Bonesi M, Piccolo V, Statti GA, Cindio B, Houghton PJ. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J. Ethnopharm., 2008; 119: 109-116.
34. Bhat M, Zinjarde SS, Bhargava SY, Kumar AR, Joshi BN. Antidiabetic Indian plants: a good source of potent amylase inhibitors. Evid. Based Complement. Alternat. Med., 2011; 2011: 6.
35. Bhutani KK, Gohil VM. Natural products drug discovery research in India: status and appraisal. Indian J Exp Biol, 2010; 48: 199-207.
36. Prashanth D, Padmaja R, Samiulla DS. Effect of certain plant extracts on [alpha]-amylase activity. Fitoterapia, 2001; 72: 179-181.
37. Wang HH, Chen CL, Jeng TL, Sung JM. Comparisons of [alpha]-amylase inhibitors from seeds of common bean mutants extracted through three phase partitioning. Food Chem., 2011; 128: 1066-1071.
38. Yamada T, Hattori K, Ishimoto M. Purification and characterization of two [alpha]-amylase inhibitors from seeds of tepary bean (Phaseolus acutifolius A. Gray). Phytochemistry, 2001; 58: 59-66.
39. Le Berre-Anton V, Bompard-Gilles C, Payan F, Rougé P. Characterization and functional properties of the [alpha]-amylase inhibitor ([alpha]-AI) from kidney bean (Phaseolus vulgaris) seeds. Biochim. Biophys. Acta, 1997; 1343: 31-40.
40. Svensson B, Fukuda K, Nielsen PK, Bonsager BC. Proteinaceous a-amylase inhibitors. Biochim Biophys. Acta, 2004; 1696: 145-156.
41. Lo Piparo E, Scheib H, Frei N, Williamson G, Grigorov M, Chou CJ. Flavonoids for Controlling Starch Digestion: Structural Requirements for Inhibiting Human α-Amylase. J. Med. Chem., 2008; 51: 3555-3561.
42. Yoon SH, Robyt JF. Study of the inhibition of four alpha amylases by acarbose and its 4IV-α-maltohexaosyl and 4IV-α-maltododecaosyl analogues. Carbohydr. Res., 2003; 338: 1969-1980.
43. Gyémánt G, Kandra L, Nagy V, Somsák L. Inhibition of human salivary α-amylase by glucopyranosylidene-spiro-thiohydantoin. Biochem Biophys Res Commun, 2003; 312: 334-339.
44. Kwon YI, Apostolidis E, Shetty K. In vitro studies of eggplant (Solanum melongena) phrnolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour Technol, 2008; 99: 2981-2988.
45. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet, 2002; 359: 2072-2077.
46. Murai A, Iwamura K, Takada M, Ogawa K, Usui T, Okamura J. Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice. Life Sci., 2002; 71: 1405-1415.
47. Lankisch M, Layer P, Rizza RA, DiMagno EP. Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans. Pancreas, 1998; 17: 176-181.
48. Boivin M, Flourie B, Rizza RA, Go VL, DiMagno EP. Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Gastroenterology, 1988; 94: 387-394.
49. Koh LW, Wong LL, Loo YY, Kasapis S, Huang D. Evaluation of Different Teas against Starch Digestibility by Mammalian Glycosidases. J Agric. Food Chem., 2010; 58: 148-154.
50. Brownlee M. The Pathobiology of Diabetic Complications: A Unifying Mechanism. Diabetes, 2005; 54: 1615-1625.
51. Kandra L, Gyémánt G, Zajácz A, Battab G. Inhibitory effects of tannin on human salivary aamylase. Biochem Biophys Res Commun, 2004; 319: 1265-1271.
52. Quideau S, Jourdes M, Saucier C, Glories Y, Pardon P, Baudry C. DNA topoisomerase inhibitor acutissimin A and other flavano-ellagitannins in red wine. Angew Chem. Int. Ed., 2003; 42: 6012-6014.
53. Gin H, Rigalleau V, Caubet O, Aubertin J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin dependent diabetic patients and on starch digestibility in vitro. Metabolism, 1999; 48: 1179-1183.
54. Zajácz A, Gyémént G, Vittorib N, Kandraa L. Aleppo tannin: structural analysis and salivary amylase inhibition. Carbohydr. Res., 2007; 342: 717-723.
55. McGarvey DJ, Croteau R. Terpenoid metabolism. Plant Cell, 1995; 7: 1015-1026.
56. Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep, 1999; 16: 221-240.
57. Xu R, Fazio GC, Matsuda SPT. On the origins of triterpenoid skeletal diversity. Phytochemistry, 2004; 65: 261-291.
58. Melo CL, Queiroz MG, Arruda Filho ACV, Rodrigues AM, Sousa DF, Almeida JG, Pessoa ODL, Silveira ER, Menezes DB, Melo TS, Santos FA, Rao VS. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. J. Agric. Food Chem., 2009; 57: 8776-8781.
59. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urban M, Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep, 2006; 23: 394-411.
60. Tang X, Gao J, Chen J, Fang F, Wang Y, Dou H, Xu Q, Qian Z. Inhibition of ursolic acid on calcium-induced mitochondrial permeability transition and release of two proapoptotic proteins Biochem. Biophys. Res. Comm., 2005; 11: 320-324.
61. Jeong HG, Kim HG, Hwang YP. Involvement of cytokines in the hepatic expression of metallothionein by ursolic acid Toxicol Lett, 2005; 155: 369-376.
62. Kim JS, Kwon CS, Son KH. Inhibition of alphaglucosidase and amylase by luteolin, a flavonoid Biosc. Biotechnol. Biochem., 2000; 64: 2458-2461.
63. McCue PP, Shetty K. Inhibitoy effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nut., 2004; 13: 101-106.
64. Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal. Chem., 1959; 31: 426-428.
65. Fuwa H. A New method for microdetermination of amylase activity by the use of amylose as the substrate. J. Biochem, 1954; 41: 583-603.
66. Subramanian R, Asmawi MZ, Sadikun A. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim. Pol., 2008; 55: 391-398.
67. Shirosaki M, Koyama T, Yazawa K. Antihyperglycemic activity of kiwifruit leaf (Actinidia deliciosa) in mice. Biosc. Biotechnol. Biochem., 2008; 72: 1099-1102.
68. Al-Dabbas MM, Kitahara K, Suganuma T, Hashimoto F, Tadera K. Antioxidant and a-Amylase Inhibitory Compounds from Aerial Parts of Varthemia iphionoides Boiss. Biosci. Biotech. Biochem., 2006; 70: 2178-2184.
69. Silva Pinto M, Kwon YI, Apostolidis E, Lajolo FM, Genovese MI, Shetty K. Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models. Biores. Technol., 2009; 100: 6599-6609.
70. Ali H, Houghton PJ, Soumyanath A. alpha amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J. Ethnopharmacol., 2006; 107: 449-455.
71. Giri AP, Kachole MS. Amylase inhibitors of pigeonpea (Cajanus cajan) seeds. Phytochemistry, 1998; 47: 197-202.
72. Guzman-Partida A, Jatomea-Fino O, Robles-Burgueño M, Ortega-Nieblas M, Vazquez-Moreno L. Characterization of [alpha]-amylase inhibitor from Palo Fierro seeds. Plant Physiology and Biochemistry, 2007; 45: 711-715.
73. Hansawasdi C, Kawabata J, Kasai T. α-Amylase Inhibitors from Roselle (Hibiscus sabdariffa Linn.) Tea. Biosc. Biotechnol. Biochem., 2000; 64: 1041-1043.
74. Thalapaneni NR, Chidambaram KA, Ellappan T, Sabapathi ML, Mandal SC. Inhibition of Carbohydrate Digestive Enzymes by Talinum portulacifolium (Forssk) Leaf Extract. J. Complem. Integr. Med., 2008; 5: 11.
75. Bhandari MR, Jong-Anurakkun N, Gao Hong JK. a-Glucosidase and a-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw.). Food Chem, 2008; 106: 247-252.
76. Mohamed GA. Alliuocide G, a new flavonoid with potent α-amylase inhibitory activity from Allium cepa L. Arkivoc, 2008; 9: 202-209.
77. Kawaguchi M, Tanabe H, Nagamine K. Isolation and characterization of a novel flavonoid possessing a 4,2"-glycosidic linkage from green mature acerola (Malpighia emarginata DC.) fruit. Biosc. Biotechnol. Biochem., 2007; 71: 1130-1135.
78. Jullian C, Miranda S, Zapata-Torres G, Mendizábalc F, Olea-Azarb C. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling. Bioorg. Med. Chem., 2007; 15: 3217-3224.
79. Fred-Jaiyesimi A, Kio A, Richard W. α-Amylase inhibitory effect of 3β-olean-12-en-3-yl (9Z)-hexadec-9-enoate isolated from Spondias mombin leaf Food Chem, 2009; 116: 285-288.
80. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J. Agric. Food Chem., 2005; 53: 2760-2766.
81. Ani V, Akhilender Naidu K. Antihyperglycemic activity of polyphenolic components of black/bitter cumin Centratherum anthelminticum (L.) Kuntze seeds. Eu Food Res Technol, 2008; 226: 897-903.